atorvastatin has been researched along with colchicine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nidorf, M; Thompson, PL | 1 |
| Bonbled, F; Hantson, P; Huberlant, V; Montiel, V; Vincent, MF | 1 |
| Enache, I; Garrouste, C; Heng, AE; Kaysi, S; Philipponnet, C; Tiple, A | 1 |
| Davis, MW; Wason, S | 1 |
| Cen, C; Ding, X; Huang, C; Wang, C; Zhan, H | 1 |
| Gonzalo-Martinez, JF; Herrero-San Martin, A; Ostos-Moliz, F; Sanchez-Tejerina San Jose, D; Toldos-Gonzalez, O | 1 |
| Abudalou, M; Al Sbihi, A; Mohamed, AS; Vega, EA | 1 |
| Bellandi, F; Biagini, F; Comeglio, M; Leoncini, M; Magnaghi, G; Maioli, M; Martini, O; Toso, A; Villani, S | 1 |
1 review(s) available for atorvastatin and colchicine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for atorvastatin and colchicine
| Article | Year |
|---|---|
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
Topics: Aspirin; Atorvastatin; Biomarkers; C-Reactive Protein; Colchicine; Coronary Angiography; Coronary Artery Disease; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Pyrroles; Treatment Outcome | 2007 |
Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions.
Topics: Adult; Anticholesteremic Agents; Area Under Curve; Atorvastatin; Colchicine; Drug Interactions; Fasting; Female; Gout Suppressants; Healthy Volunteers; Heptanoic Acids; Humans; Male; Pyrroles; Young Adult | 2014 |
Rationale and design of COLchicine On-admission to Reduce inflammation in Acute Coronary Syndrome (COLOR-ACS) study.
Topics: Acute Coronary Syndrome; Atorvastatin; C-Reactive Protein; Colchicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Treatment Outcome | 2023 |
8 other study(ies) available for atorvastatin and colchicine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management.
Topics: Adult; Atorvastatin; Colchicine; Critical Care; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Overdose; Female; Heptanoic Acids; Humans; Multiple Organ Failure; Propofol; Pyrroles; Rhabdomyolysis | 2010 |
Severe colchicine intoxication in a renal transplant recipient on cyclosporine.
Topics: Acute Kidney Injury; Atorvastatin; Colchicine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrroles; Quadriplegia; Rhabdomyolysis; Treatment Outcome | 2012 |
Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Atorvastatin; C-Reactive Protein; Colchicine; Diet, High-Fat; Heptanoic Acids; Hyperlipidemias; Male; Nitrogen Oxides; Pyrroles; Rats; Rats, Sprague-Dawley | 2014 |
[Toxic myopathy associated with concomitant treatment with atorvastatin and colchicine].
Topics: Aged; Arthritis, Gouty; Atorvastatin; Biopsy; Colchicine; Diabetes Mellitus, Type 2; Drug Synergism; Dyslipidemias; Electromyography; Humans; Kidney Failure, Chronic; Male; Muscle, Skeletal; Muscular Diseases; Quadriplegia | 2019 |
Colchicine-induced rhabdomyolysis: a review of 83 cases.
Topics: Aged; Atorvastatin; Colchicine; Coronary Artery Bypass; Humans; Male; Pericardial Effusion; Rhabdomyolysis | 2021 |